The purpose of this study was to verify the effect of cordycepin on ovariectomized osteopenic rats. Fifty Wistar female rats used were divided into 5 groups: (1) sham-operation rats (control), (2) ovariectomized (OVX) rats with osteopenia, and (3) OVX'd rats with osteopenia treated with cordycepin (5 mg, 10 mg, and 20 mg) for 8 weeks. After the rats were treated orally with cordycepin, serum alkaline phosphatase (ALP), tartrate resistant acid phosphatase (TRAP), serum osteocalcin (OC), homocysteine (HCY) , C-terminal crosslinked telopeptides of collagen type I (CTX) level, and oxidative stress were examined, respectively. The femoral neck was used for mechanical compression testing. At the same time, we further investigated the effect of cordycepin in vitro assay. The beneficial effects of cordycepin on improvement of osteoporosis in rats were attributable mainly to decrease ALP activity, TRAP activity, and CTX level. At the same time, cordycepin also increases the OC level in ovariectomized osteopenic rats. The histological examination clearly showed that dietary cordycepin can prevent bone loss caused by estrogen deficiency. These experimental results suggest that complement cordycepin is protective after ovariectomized osteopenic in specific way.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385597 | PMC |
| http://dx.doi.org/10.1155/2015/423869 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effects of Cannabidiol on Bone Quality in Ovariectomized Rats.
Calcif Tissue Int
November 2024
Ribeirao Preto Medical School, University of Sao Paulo, Rua Pedreira de Freitas, s/n, Ribeirao Preto, Sao Paulo, 14090092, Brazil.
The incidence of osteoporosis and related fractures increases significantly with age, impacting public health and associated costs. Postmenopausal osteoporosis results from increased bone resorption due to decreased estrogen levels. The endocannabinoid system, especially cannabidiol (CBD), has shown therapeutic potential in modulating bone formation.
View Article and Find Full Text PDFOsteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy.
Arch Pharm Res
September 2024
Division of Endocrinology and Centre for Research in Anabolic Skeletal Targets in Health and Illness (ASTHI), CSIR-Central Drug Research Institute, Sector 10, Jankipuram Extension, Sitapur Road, Lucknow, 226031, India.
Article Synopsis
- Adiponectin is a protein that helps control how our bodies use sugar and fat, and there's a special piece of it called ADP-1 that can help build bones better than the whole protein.
- Researchers found that ADP-1 helps bone cells called osteoblasts grow and work by using two different methods, one involving energy production and the other involving a signaling pathway important for bone health.
- In tests on rats with weak bones, ADP-1 improved bone strength and structure by encouraging new bone formation and stopping the breakdown of old bone, which could help people with osteoporosis.
Anti-Microbial Drug Metronidazole Promotes Fracture Healing: Enhancement in the Bone Regenerative Efficacy of the Drug by a Biodegradable Sustained-Release In Situ Gel Formulation.
Biomedicines
July 2024
Division of Endocrinology, CSIR-Central Drug Research Institute, Council of Scientific and Industrial Research, Lucknow 226031, India.
Nitroimidazoles comprise a class of broad-spectrum anti-microbial drugs with efficacy against parasites, mycobacteria, and anaerobic Gram-positive and Gram-negative bacteria. Among these drugs, metronidazole (MTZ) is commonly used with other antibiotics to prevent infection in open fractures. However, the effect of MTZ on bone remains understudied.
View Article and Find Full Text PDFHakai, a novel Runx2 interacting protein, augments osteoblast differentiation by rescuing Runx2 from Smurf2-mediated proteasome degradation.
J Cell Physiol
September 2024
Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India.
Article Synopsis
- Runx2 is super important for making bones, and without it, baby animals can't grow bones and die after birth.
- We found a protein called Hakai that helps Runx2 work better and is also linked to bone health.
- When we increased Hakai in lab tests, it helped cells turn into bone-making cells, but if we changed Hakai to a non-working form, it didn't help at all.
RING finger E3 ligase, RNF138 inhibits osteoblast differentiation by negatively regulating Runx2 protein turnover.
J Cell Physiol
May 2024
Division of Cancer Biology, CSIR-Central Drug Research Institute, Lucknow, Utter Pradesh, India.
A few ubiquitin ligases have been shown to target Runx2, the key osteogenic transcription factor and thereby regulate bone formation. The regulation of Runx2 expression and function are controlled both at the transcriptional and posttranslational levels. Really interesting new gene (RING) finger ubiquitin ligases of which RNF138 is a member are important players in the ubiquitin-proteasome system, contributing to the regulation of protein turnover and cellular processes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!